These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1238994)

  • 41. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin.
    Hall JE; Guyton AC; Smith MJ; Coleman TG
    Am J Physiol; 1980 Sep; 239(3):F271-80. PubMed ID: 6254369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of glomerular filtration rate: role of intrarenally formed angiotensin II.
    Kastner PR; Hall JE; Guyton AC
    Am J Physiol; 1984 Jun; 246(6 Pt 2):F897-906. PubMed ID: 6377913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II.
    Kastner PR; Hall JE; Guyton AC
    Am J Physiol; 1982 Sep; 243(3):F260-4. PubMed ID: 7051857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal uninephrectomy in male sheep alters the systemic and renal responses to angiotensin II infusion and AT1R blockade.
    Singh RR; Moritz KM; Wintour EM; Jefferies AJ; Iqbal J; Bertram JF; Denton KM
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F319-26. PubMed ID: 21543419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic blockade of angiotensin II formation during sodium deprivation.
    Hall JE; Guyton AC; Smith MJ; Coleman TG
    Am J Physiol; 1979 Dec; 237(6):F424-32. PubMed ID: 391063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
    Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
    Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lead and nickel alter the cardiorenal actions of endothelin in the rat.
    Novak J; Banks RO
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):191-8. PubMed ID: 7831352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER; Burrell JH; Menzies RI; Stevens AD
    Br J Pharmacol; 1993 Oct; 110(2):821-7. PubMed ID: 8242257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of exogenous angiotensin II on renal hemodynamics in the awake rat. Measurement of afferent arteriolar diameter by the microsphere method.
    Hsu CH; Kurtz TW; Slavicek JM
    Circ Res; 1980 May; 46(5):646-50. PubMed ID: 7363414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension.
    Huelsemann JL; Sterzel RB; McKenzie DE; Wilcox CS
    Hypertension; 1985; 7(3 Pt 1):374-9. PubMed ID: 3158602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet.
    Spiering W; Kroon AA; Fuss-Lejeune MM; Daemen MJ; de Leeuw PW
    Hypertension; 2000 Sep; 36(3):411-6. PubMed ID: 10988274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo cardiovascular pharmacology of 2',3'-cAMP, 2'-AMP, and 3'-AMP in the rat.
    Jackson EK; Mi Z
    J Pharmacol Exp Ther; 2013 Aug; 346(2):190-200. PubMed ID: 23759508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intrarenal angiotensin II infusion on the renal escape from mineralocorticoid.
    Opgenorth TJ; Granger JP; Chakravarthy A; Knox FG; Romero JC
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F813-8. PubMed ID: 4073265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects on renal hemodynamics of intra-arterial infusions of angiotensins I and II.
    Rosivall L; Navar LG
    Am J Physiol; 1983 Aug; 245(2):F181-7. PubMed ID: 6881336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A proposed role for adenosine in the regulation of renal hemodynamics and renin release.
    Spielman WS; Thompson CI
    Am J Physiol; 1982 May; 242(5):F423-35. PubMed ID: 7044144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of altered NaCl intake on renal hemodynamic and renin release responses to RNS.
    Osborn JL; Kinstetter DD
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F976-81. PubMed ID: 3318501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.